The Company is increasing its revenue guidance for the year ending December 31 to be $15M – $15.5M, as compared to its previous guidance of $14M- $15M. Consensus is $14.43M.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ECOR:
- electroCore Announces Third Quarter 2023 Financial Results
- electroCore announces data from abstract on nVNS
- Data Highlighting Non-invasive Vagus Nerve Stimulation (nVNS) for Treatment of Symptoms of Gastroparesis Presented at 2023 American College of Gastroenterology Annual Meeting
- electroCore Announces Two-Year Extension of gammaCore™ Device Listing in the NHS Supply Chain Catalogue
- electroCore announces extension of gammaCore device listing in NHS Supply Chain
